Dec 22, 2020 9:00am
Drugmakers believe COVID-19 may change the ways of working for good, even after the pandemic eases. (Getty Images)
As COVID-19 vaccines are rolling out in different parts of the world, perhaps it’s finally time to talk about life after the pandemic. But biopharma companies believe it’s too early to put a specific timeline on turning that page now.
Despite all the unknowns, though, one thing seems certain: How drugmakers conduct their business will change.
After navigating the past few months, “one thing is clear to us: We will not return to the old ways of working after the corona pandemic,” Bayer spokesman Markus Siebenmorgen said.